Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06128902
Other study ID # Tele-nursing
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2022
Est. completion date May 30, 2023

Study information

Verified date November 2023
Source T.C. ORDU ÜNIVERSITESI
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic obstructive pulmonary disease (COPD); From time to time, significant involvement in dusts or gases and abnormal disease outbreaks are observed, which are observed throughout life in the period when the cause has just emerged, interruption of air flow with disruptions in air flow, shortness of breath, increase in the amount of secretion. Directly or indirectly, very high costs are incurred in COPD care and promotion. While mild stages are treated without directed hospitalization, hospitalizations become more frequent as the disease progresses, and the duration of hospitalization in each acute attack increases compared to the next attack. Acute exacerbations of COPD negatively affect the rates of rehospitalization and emergency service admissions, and the living conditions of this condition, whose long-term cause of death and morbidity has not yet been revealed, do not lead to negative aspects. Exercise programs applied in chronic diseases should include stopping their illnesses, increasing sleep during the disease, stopping inflammatory acuteness, and in addition to treatment, the rest of the patients should be normal. It has been stated that it is more effective than home-based hospital system applications in pulmonary regulation, and it has been taken positively from applications compatible with the basic field, as everywhere in the world. In this direction, the effect of home-based monitoring, education and exercise training applied to individuals with COPD via tele-consultancy method on repeated hospitalization and quality of life is revealed.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 30, 2023
Est. primary completion date May 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Agreeing to participate in the research, - Diagnosed with COPD, - Able to use a smartphone, - Oriented and cooperative, - Does not have a psychiatric disorder that impairs verbal communication, such as schizophrenia or dementia, - Having no communication problems. Exclusion Criteria: - Having alcohol or drug addiction, - Those with physical disabilities, - Illiterate.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
tele health
home based exercise and telenursing

Locations

Country Name City State
Turkey Nejla KOKSAL Ordu

Sponsors (1)

Lead Sponsor Collaborator
T.C. ORDU ÜNIVERSITESI

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary repeated hospitalizations after randomization and 12 weeks later They will be questioned about the number of times they were admitted to hospital due to COPD during 12 weeks.
Secondary Quality of life that COPD patients after randomization and 12 weeks later Their quality of life will be evaluated with the SF-36 quality of life (Short Form) immediately after randomization and 12 weeks later.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05980611 - Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients
Recruiting NCT00949195 - Pulmonary Arterial Pressure Response During Exercise N/A
Completed NCT01475812 - Daily Activities Are Sufficient to Induce Dynamic Pulmonary Hyperinflation and Dyspnea in Chronic Obstructive Pulmonary Disease Patients N/A
Completed NCT02157935 - Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease Phase 3
Completed NCT01183052 - Mitochondrial Dysfunction and Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD) Patients N/A
Withdrawn NCT00180622 - Markers for Chronic Obstructive Pulmonary Disease (COPD)
Completed NCT04869033 - Effects of Farinelli's Breathing Exercise in COPD Patients N/A
Completed NCT02099279 - Prognostic Value Cardiac Dysfunction Assessed by Bedside Echocardiography in Critically Ill COPD Patients Requiring Mechanical Ventilation N/A
Withdrawn NCT00361426 - EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients N/A
Recruiting NCT03774238 - Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients N/A
Enrolling by invitation NCT03851991 - The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD. Phase 4